FEMA ADVISORY – June 2, 2020
Coronavirus Pandemic: Whole-of-America Response
Attached you will find today’s Daily Briefing Points and the Regional Supplemental for the Whole-of-America response to the coronavirus (COVID-19) pandemic. These briefing points include Topline Messages, as well as information By the Numbers; Supply Chain Task Force; FEMA and Department of Health and Human Services Response; and Guidance from Federal Agencies. The Regional Supplemental highlights the updated numbers by states and regions.
Topline messaging includes:
- On June 1, HHS announced a task order with Emergent BioSolutions to advance manufacturing capabilities for a potential COVID-19 vaccine as well as therapeutics. Under the order, Emergent will commit contract development and manufacturing organization drug substance and drug product manufacturing capacity valued at approximately $542.75 million for production of COVID-19 vaccine candidates through 2021.
- As of June 1, FEMA has made 7,360 deliveries of medical supplies to nursing homes to all 53 states and territories. FEMA is coordinating two shipments totaling a 14-day supply of personal protective equipment to all 15,400 Medicaid and Medicare-certified nursing homes. The shipments are meant to supplement existing efforts to provide equipment to nursing homes.
- As of June 1, FEMA, HHS, and the private sector combined have coordinated the delivery of or are currently shipping: 92.2 million N95 respirators, 147.3 million surgical masks, 13.7 million face shields, 36.1 million surgical gowns and over 1 billion gloves.
- To support the Administration’s Testing Blueprint, FEMA is working to source and procure testing material – specifically, testing swabs and transport media.
- FEMA has procured and delivered 13.1 million swabs and 8.6 million units of media so far in the month of May.
- The FEMA-sourced material will be provided to states, territories and tribes for a limited duration to help increase testing capacity in support of their individualized plans.
- As of June 1, CDC, state, and local public health labs and other laboratories have tested more than 16.7 million samples.
- As of May 29, the FDA has issued 114 individual emergency use authorizations (EAU) for test kit manufacturers and laboratories, including 12 antibody tests and one antigen test.
If you have any questions regarding this FEMA Advisory, please contact FEMA Office of External Affairs, Congressional and Intergovernmental Affairs Division:
Follow FEMA on social media at: Visit the FEMA Blog, follow @FEMA or @FEMAEspanol on Twitter, FEMA or FEMA Espanol on Facebook, @FEMA on Instagram, and view videos on the FEMA YouTube channel, and Administrator Pete Gaynor on Twitter @FEMA_Pete.
To help people before, during and after disasters.